CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Shares Outstanding (Entity) (2021 - 2025)

Updated

CytoMed Therapeutics (GDTC) recorded Shares Outstanding (Entity) of 11.83 million in Q4 2025, up 2.5% from 11.54 million a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Shares Outstanding (Entity) (2021 - 2025) Analysis & Trends

Starting with Q4 2021, CytoMed Therapeutics' Shares Outstanding (Entity) history includes 5 quarters.

  • Annual Shares Outstanding (Entity) has a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
  • Across earlier years, Shares Outstanding (Entity) came in at 11.54 million in FY2024 (unchanged), 11.54 million in FY2023 (+45.8%), 7.92 million in FY2022 (+5.8%) and 7.48 million in FY2021 (+23.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11.83 Mn
Dec 31, 2024 11.54 Mn
Dec 31, 2023 11.54 Mn
Dec 31, 2022 7.92 Mn
Dec 31, 2021 7.48 Mn
API Access

CytoMed Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=GDTC&period=max&api_key=YOUR_API_KEY